Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 1
2000 1
2004 2
2005 1
2012 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma.
Suprasert P, Cheewakriangkrai C, Manopunya M. Suprasert P, et al. Asian Pac J Cancer Prev. 2012;13(2):517-20. doi: 10.7314/apjcp.2012.13.2.517. Asian Pac J Cancer Prev. 2012. PMID: 22524817 Free article.
The median progression free survival and overall survival was 2 and 10 months, respectively. With the total 550 courses of chemotherapy, the patients developed grades 3 and 4 hematologic toxicity as follows: anemia, 1.5%; leukopenia, 13.7%; neutropenia, 27.3%; and thromboc …
The median progression free survival and overall survival was 2 and 10 months, respectively. With the total 550 courses of chemothera …
Concurrent ovarian-type primary peritoneal adenocarcinoma and peritoneal choriocarcinoma. A case report and review of the literature.
Pentheroudakis G, White J, Davis J, Brown I, Vasey P. Pentheroudakis G, et al. Gynecol Oncol. 2004 Feb;92(2):697-700. doi: 10.1016/j.ygyno.2003.10.049. Gynecol Oncol. 2004. PMID: 14766269 Review.
CASE: A 65-year old female with stage IV primary peritoneal carcinoma, ovarian type, underwent surgical cytoreduction followed by two courses of paclitaxel/carboplatin chemotherapy. A choriocarcinomatous component was later identified in the resection specimens, as chemoth …
CASE: A 65-year old female with stage IV primary peritoneal carcinoma, ovarian type, underwent surgical cytoreduction followed by two cou …
Extreme drug resistance assay and response to chemotherapy in patients with primary peritoneal carcinoma.
Eltabbakh GH. Eltabbakh GH. J Surg Oncol. 2000 Mar;73(3):148-52. doi: 10.1002/(sici)1096-9098(200003)73:3<148::aid-jso7>3.0.co;2-u. J Surg Oncol. 2000. PMID: 10738268
BACKGROUND AND OBJECTIVES: The extreme drug resistance (EDR) assay is an in vitro chemoresistance assay performed on tumor samples grown in culture and is claimed to predict drugs unlikely to produce response. Its clinical value in patients with epithelial ovarian cancer ( …
BACKGROUND AND OBJECTIVES: The extreme drug resistance (EDR) assay is an in vitro chemoresistance assay performed on tumor samples grown in …
Primary peritoneal adenocarcinoma metastatic to the brain.
Eltabbakh GH, Piver MS, Werness BA. Eltabbakh GH, et al. Gynecol Oncol. 1997 Jul;66(1):160-3. doi: 10.1006/gyno.1997.4776. Gynecol Oncol. 1997. PMID: 9234939
The incidence of central nervous system metastases in 72 patients with documented primary peritoneal adenocarcinoma was 1.4%. The risk factors, clinical behavior, and prognosis of patients with primary peritoneal adenocarcinoma metastatic to the central nervous system seem …
The incidence of central nervous system metastases in 72 patients with documented primary peritoneal adenocarcinoma was 1.4%. The risk facto …
Importance of lymph node metastases in primary peritoneal carcinoma.
Eltabbakh GH, Piver MS, Hempling RE, Werness BA, Blumenson LE. Eltabbakh GH, et al. J Surg Oncol. 1998 Jul;68(3):144-8. doi: 10.1002/(sici)1096-9098(199807)68:3<144::aid-jso2>3.0.co;2-5. J Surg Oncol. 1998. PMID: 9701204
CONCLUSIONS: Lymph node involvement is not an infrequent occurrence in patients with PPA and does not seem to be of adverse prognostic significance....
CONCLUSIONS: Lymph node involvement is not an infrequent occurrence in patients with PPA and does not seem to be of adverse prognostic …